29 May 2018 07:00
News Release
London, 27 May 2018
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
Sunday 27 May 2018
Smiths Group plc ("Smiths")
Statement regarding Smiths Medical
Smiths notes the press speculation regarding discussions involving its Smiths Medical business and confirms that it is in very early stage discussions about a potential combination of its medical division with ICU Medical, Inc. (NASDAQ: ICUI).
The Board of Smiths routinely reviews all options for the Group's portfolio of businesses to maximise value for Smiths shareholders.
There can be no certainty that a transaction will be concluded.
END
Contact details
| |
Investor enquiries | |
Jemma Spalton, Smiths Group +44 (0)20 7004 1637 +44 (0)78 6739 0350 jemma.spalton@smiths.com
| Marion Le Bot, Smiths Group+44 (0)20 7004 1672+44 (0)75 8315 4386marion.lebot@smiths.com
|
Media enquiries | |
Deborah Scott, FTI Consulting+44 (0)20 3727 1459+44 (0)797 953 7449smiths@fticonsulting.com
| Alex Le May, FTI Consulting+44 (0)20 3727 1308+44 (0)7702 443 312smiths@fticonsulting.com
|
About Smiths Group
Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the medical technology, security & defence, general industrial, oil & gas, and space & aerospace markets worldwide. Smiths Group employs c.22,000 colleagues in over 50 countries. For more information visit www.smiths.com.
About Smiths Medical
Smiths Medical is a leading supplier of specialised medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. For more information visit www.smiths-medical.com.
Smiths Group (SMIN)